Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
NCT00049452
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Osteoporosis
Interventions
DRUG:
zoledronic acid
Sponsor
Herbert Irving Comprehensive Cancer Center
Collaborators
[object Object]